Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 6/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | PPARD | Q03181 | 7/20 | 0.54 |
| ▸ | PPARA | Q07869 | 7/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.54 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26302700 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL2553415 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL849975 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL1285325 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL18992918 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL2556960 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL3121839 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL2137289 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL21655426 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL7199372 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0327523-B1 | NOVEL FATTY ACID ANALOG ENZYME SUBSTRATES | WASHINGTON UNIVERSITY (US) | 1992-06-17 | — | — | EP | claimed |
| EP-0327523-A1 | Novel fatty acid analog enzyme substrates | WASHINGTON UNIVERSITY (US) | 1989-08-09 | — | — | EP | claimed |
| US-11680034-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | PTC THERAPEUTICS, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| US-11680034-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | PTC THERAPEUTICS, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| US-20210238119-A1 | FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | PTC THERAPEUTICS, INC. | 2021-08-05 | — | — | US | disclosed |
| CN-113024369-A | Compounds for the treatment of oxidative stress disorders | PTC医疗公司 | 2021-06-25 | — | — | CN | disclosed |
| US-10981855-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | PTC THERAPEUTICS, INC. (US) | 2021-04-20 | — | — | US | disclosed |
| US-10981855-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | PTC THERAPEUTICS, INC. (US) | 2021-04-20 | — | — | US | disclosed |
| US-20200331835-A1 | FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | PTC THERAPEUTICS, INC. | 2020-10-22 | — | — | US | disclosed |
| US-20200331835-A1 | FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | PTC THERAPEUTICS, INC. | 2020-10-22 | — | — | US | disclosed |
| US-10703701-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | PTC THERAPEUTICS, INC. (US) | 2020-07-07 | — | — | US | disclosed |
| EP-0636134-A1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-02-01 | — | — | EP | disclosed |
| WO-1993021191-A1 | NOVEL ACYLATED PHOSPHOLIPID DRUGS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-10-28 | — | — | WO | disclosed |
| EP-0415902-B1 | OXY- OR THIO-SUBSTITUTED FATTY ACID ANALOGS FOR USE IN THE TREATMENT OF RETROVIRAL INFECTIONS | WASHINGTON UNIVERSITY (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5151445-A | Method of inhibiting parasitic activity | WASHINGTON UNIVERSITY (US) | 1992-09-29 | — | — | US | disclosed |
| EP-0498783-A2 | Method of inhibiting parasitic activity | WASHINGTON UNIVERSITY (US) | 1992-08-12 | — | — | EP | disclosed |
| EP-0327523-B1 | NOVEL FATTY ACID ANALOG ENZYME SUBSTRATES | WASHINGTON UNIVERSITY (US) | 1992-06-17 | — | — | EP | disclosed |
| US-5073571-A | Oxy or thio substituted fatty acid or ester | WASHINGTON UNIVERSITY (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0415902-A1 | Oxy- or thio-substituted fatty acid analogs for use in the treatment of retroviral infections | WASHINGTON UNIVERSITY (US) | 1991-03-06 | — | — | EP | disclosed |
| EP-0327523-A1 | Novel fatty acid analog enzyme substrates | WASHINGTON UNIVERSITY (US) | 1989-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10703701-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | NFE2L2, NQO1, ALDH2 | ALDH1A1 312/4885TSHR 2889/4885LMNA 505/4885 |
| US-10981855-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | NFE2L2, NQO1, ALDH2 | ALDH1A1 312/4885TSHR 2889/4885LMNA 505/4885 |
| US-20210238119-A1 | FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | NFE2L2, NQO1, ALDH2 | ALDH1A1 312/4885TSHR 2889/4885LMNA 505/4885 |
| US-11680034-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | NFE2L2, NQO1, ALDH2 | ALDH1A1 312/4885TSHR 2889/4885LMNA 505/4885 |
| US-20200331835-A1 | FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | NFE2L2, NQO1, ALDH2 | ALDH1A1 312/4885TSHR 2889/4885LMNA 505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.